Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19043153 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Olanzapine in Patients With Borderline Personality Disorder
Condition: Borderline Personality Disorder
Interventions: Drug: Olanzapine;   Drug: placebo

Study has passed its completion date and status has not been verified in more than two years.